Akcea Therapeutics, Inc.

Historical 13F Holders

Symbol
AKCA
CUSIP
00972L107
All holders as of
Q2 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q2 1 0 $0
2021 Q1 1 0 $0
2020 Q4 1 0 $0
2020 Q3 107 15.8 M $287 M
2020 Q2 93 19.6 M $268 M
2020 Q1 89 20.4 M $292 M
2019 Q4 88 21.2 M $358 M
2019 Q3 71 22.0 M $338 M
2019 Q2 84 23.8 M $559 M
2019 Q1 91 23.5 M $665 M
2018 Q4 71 23.6 M $711 M
2018 Q3 86 23.4 M $820 M
2018 Q2 63 22.8 M $541 M
2018 Q1 62 20.6 M $526 M
2017 Q4 58 19.4 M $337 M
2017 Q3 45 17.3 M $480 M